|
|
 |
|
|
Reference Library |
|
|
Below is a reference list that includes an article describing the pivotal clinical trial and studies demonstrating the safety and efficacy of Luxíq (betamethasone
valerate) Foam, 0.12%, an article reviewing patient compliance with psoriasis medications, and an article comparing coverage areas of psoriasis medications.
|
|
- Feldman SR, Sangha N, Setaluri V. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. J Am Acad Dermatol. 2000;42(6):1017-1020.
- Franz TJ, Parsell DA, Halualani RM, et al. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol. 1999;38:628-632.
- Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CEM. Patients
with psoriasis and their compliance with medication. J Am Acad
Dermatol. 1999;41(4):581-583.
|
|
|
